Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats

NeuroReport

Volumn 9, Issue 15, 1998, Pages 3481-3486

  Fink jensen, Anders ^a   Kristensen, Peter ^a   Shannon, Harlan E ^b   Calligaro, David O ^b   Delapp, Neil W ^b   Whitesitt, Cilia ^b   Ward, John S ^b   Thomsen, Christian ^a   Rasmusseen, Thøger ^a   Sheardown, Malcolm J ^a   Jeppesen, Lone ^a   Sauerberg, Per ^a   Bymaster, Frank P ^b  

^a NOVO NORDISK A S   (Denmark)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

6 OHDA; Antipsychotic; Cholinergics; Fos; Muscarinics; Rotation

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 (3 PROPYLTHIO 1,2,5 THIADIAZOL 4 YL) 1 AZABICYCLO[3.2.1]OCTANE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; MUSCARINIC AGENT; OXOTREMORINE; PILOCARPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; IMMUNOREACTIVITY; LIGAND BINDING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SALIVATION;

EID: 7844226617     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199810260-00027     Document Type: Article

References (23)

1. Seeman P, Lee T, Chau-Wong M and Wong KP. Nature 261, 717-719 (1976).
2. Pfeiffer, CC and Jenney, EH. Ann NY Acad Sci 66, 653-664 (1957).
3. Chalmers RK and Erickson CK. Psychopharmacologia 8, 31-41 (1964).
4. Karson CN, Casanova MF, Kleinman JE and Griffin WST. Am J Psychiatry 180, 454-459 (1993).
5. Yeomans JS. Neuropsychopharmacology 12, 3-16 (1995).
6. White KE and Cummings JL. Compr Psychiatry 37, 188-195 (1996).
7. Bodick NC, Offen WW, Levey, AI et al. Arch Neurol 54, 465-473 (1997).
8. Bymaster FP, Shannon HE, Rasmussen K et al. Eur J Pharmacol In press.
9. Ungerstadt U and Arbuthnott GW. Brain Res 24, 485-493 (1970)
10. Fink-Jensan A , Ludvigsen TS and Korsgaard N. Neurosci Lett 194, 77-80 (1995).
11. Robertson HA, Peterson MR, Murphy K and Robertson GS. Brain Res 503 346-349 (1989).
12. Bymaster, FP, Rasmussen, K, Calligaro DO et al. J Clin Psychiatry 58, 28-36 (1997).
13. Fink-Jensen A and Kristensen P. Neurosci Lett 182, 115-118 (1995).
14. Robertson GS, Matsumura H and Fibiger HC. J Pharmacol Exp Ther 271, 1058-1066 (1994).
15. Arnt J and Hyttel J. J Neural Transmission 67, 225-240 (1986).
16. Gao ZG, Cui WY and Liu CG. Life Sci 60, 317-323 (1997).
17. Morelli M, Fenu S, Cozzolino A et al. Neuroscience 53, 673-678 (1993).
18. Graybiel AM, Moratalla R and Robertson HA. Proc Natl Acad J Sci USA 87, 6912-6916 (1990).
19. Kebabian, JW and Calne DB. Nature 277, 93-96 (1979).
20. Stoof JC and Kebabian JW. Nature 294, 366-368 (1981).
21. Kelly E and Nahorski SR. J Neurochem 47, 1512-1516 (1986).
22. Di Chiara G, Morelli, M and Consolo S. Trends Neurosci 17, 228-233 (1994).
23. Clark D and White F. Synapse 1, 347-388 (1997).